[HTML][HTML] In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery
A Woods, A Patel, D Spina, Y Riffo-Vasquez… - Journal of Controlled …, 2015 - Elsevier
The development of clinically acceptable albumin-based nanoparticle formulations for use in
pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials …
pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials …
[PDF][PDF] In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery
S Clark, H Collins, K Bruce, LA Dailey… - Journal of Controlled …, 2015 - cyberleninka.org
A. Woods a, A. Patel a, c, D. Spina c, Y. Riffo-Vasquez c, A. Babin-Morgan a, c, RTM de
Rosales b, K. Sunassee b, S. Clark b, H. Collins d, K. Bruce a, LA Dailey a,⁎, B. Forbes aa …
Rosales b, K. Sunassee b, S. Clark b, H. Collins d, K. Bruce a, LA Dailey a,⁎, B. Forbes aa …
[HTML][HTML] In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery
A Woods, A Patel, D Spina… - Journal of Controlled …, 2015 - ncbi.nlm.nih.gov
The development of clinically acceptable albumin-based nanoparticle formulations for use in
pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials …
pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials …
[PDF][PDF] In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery
S Clark, H Collins, K Bruce, LA Dailey… - Journal of Controlled …, 2015 - researchgate.net
A. Woods a, A. Patel a, c, D. Spina c, Y. Riffo-Vasquez c, A. Babin-Morgan a, c, RTM de
Rosales b, K. Sunassee b, S. Clark b, H. Collins d, K. Bruce a, LA Dailey a,⁎, B. Forbes aa …
Rosales b, K. Sunassee b, S. Clark b, H. Collins d, K. Bruce a, LA Dailey a,⁎, B. Forbes aa …
In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery
A Woods, A Patel, D Spina, Y Riffo-Vasquez… - Journal of Controlled …, 2015 - infona.pl
The development of clinically acceptable albumin-based nanoparticle formulations for use in
pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials …
pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials …
In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery
A Woods, A Patel, D Spina… - Journal of …, 2015 - researchprofiles.herts.ac.uk
The development of clinically acceptable albumin-based nanoparticle formulations for use in
pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials …
pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials …
[PDF][PDF] King's Research Portal
A Woods, A Patel, D Spina, Y Riffo-Vasquez… - Journal of Controlled …, 2015 - core.ac.uk
A. Woods a, A. Patel a, c, D. Spina c, Y. Riffo-Vasquez c, A. Babin-Morgan a, c, RTM de
Rosales b, K. Sunassee b, S. Clark b, H. Collins d, K. Bruce a, LA Dailey a,⁎, B. Forbes aa …
Rosales b, K. Sunassee b, S. Clark b, H. Collins d, K. Bruce a, LA Dailey a,⁎, B. Forbes aa …
[引用][C] In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery
A Woods, A Patel, D Spina, Y Riffo-Vasquez… - Journal of Controlled …, 2015 - cir.nii.ac.jp
In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug
delivery | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
delivery | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery.
A Woods, A Patel, D Spina, Y Riffo-Vasquez… - Journal of Controlled …, 2015 - europepmc.org
The development of clinically acceptable albumin-based nanoparticle formulations for use in
pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials …
pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials …
[PDF][PDF] In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery
S Clark, H Collins, K Bruce, LA Dailey… - Journal of Controlled …, 2015 - research.herts.ac.uk
A. Woods a, A. Patel a, c, D. Spina c, Y. Riffo-Vasquez c, A. Babin-Morgan a, c, RTM de
Rosales b, K. Sunassee b, S. Clark b, H. Collins d, K. Bruce a, LA Dailey a,⁎, B. Forbes aa …
Rosales b, K. Sunassee b, S. Clark b, H. Collins d, K. Bruce a, LA Dailey a,⁎, B. Forbes aa …